Clinical Trial Update: Effects on Exercise Hemodynamics of Vasopressin Blockade by Conivaptan Infusion in Heart Failure Patients [Phase 4]

View source ↗

Summary

Phase 4 trial results evaluating how vasopressin blockade with conivaptan infusion affects exercise hemodynamics in heart failure patients.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Heart Failure

Drugs mentioned

• Vaprisol (Conivaptan)

Snippet

Sponsor: Finn Gustafsson | Conditions: Heart Failure | Phase 4 | Status: COMPLETED